Loading...
Loading...
Among the 6 tracked institutional investors we monitor, PTCT (PTC THERAPEUTICS INC) is held with a combined value of $2.02B across 28,573,600 shares. The largest holder is BlackRock, Inc. with a position worth $882.20M (0.02% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$2.02B
Total Shares Held
28,573,600
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $882.20M | 0.02% | +1.3% |
| 2 | VANGUARD GROUP INC | $668.69M | 0.01% | New |
| 3 | STATE STREET CORP | $296.13M | 0.01% | +3.3% |
| 4 | FMR LLC | $104.13M | 0.01% | -9.1% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $36.33M | 0.06% | -12.2% |
| 6 | CITADEL ADVISORS LLC | $28.17M | 0.00% | -64.8% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of PTCT with a position worth $882.20M, representing 0.02% of their portfolio. In total, 6 institutional investors hold PTCT with a combined value of $2.02B.
In the most recent quarter, 1 fund opened a new position in PTCT. Additionally, 2 increased their holdings and 3 reduced their positions.
Institutional investors hold $2.02B worth of PTCT stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $882.20M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PTCT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PTCT positions.